1248594

Syndax Pharmaceuticals Inc. — FEI 3030420888

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 22, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New York, NY (United States)

Additional Details

Sponsor, Contract Research Organization